KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to -$454.0 million.

  • Bausch Health Companies' Cash from Investing Activities rose 18.63% to -$83.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$513.0 million, marking a year-over-year decrease of 27.61%. This contributed to the annual value of -$454.0 million for FY2024, which is 78.83% up from last year.
  • Latest data reveals that Bausch Health Companies reported Cash from Investing Activities of -$454.0 million as of FY2024, which was up 78.83% from -$2.1 billion recorded in FY2023.
  • In the past 5 years, Bausch Health Companies' Cash from Investing Activities ranged from a high of $409.0 million in FY2021 and a low of -$2.1 billion during FY2023.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$454.0 million (2024), whereas its average is -$967.3 million.
  • Per our database at Business Quant, Bausch Health Companies' Cash from Investing Activities skyrocketed by 256.70% in 2021 and then slumped by 607.92% in 2023.
  • Yearly analysis of 5 years shows Bausch Health Companies' Cash from Investing Activities stood at -$261.0 million in 2020, then skyrocketed by 256.70% to $409.0 million in 2021, then slumped by 174.08% to -$303.0 million in 2022, then slumped by 607.92% to -$2.1 billion in 2023, then soared by 78.83% to -$454.0 million in 2024.